KiraGen Bio develops off-the-shelf, donor-derived CAR-T cell therapies utilizing multiplex precision gene editing. Their technology is designed to create robust cell therapies with intrinsic resilience against the tumor microenvironment (TME). This approach aims to deliver durable function for treating challenging indications like Glioblastoma Multiforme (GBM).
Funding
$0 raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
ZVFounders
Product
Problem
Solid tumors create immunosuppressive microenvironments that limit the efficacy and durability of CAR-T cell therapies. Traditional CAR-T cell approaches struggle to overcome these barriers, resulting in limited success in treating solid tumors.
Solution
KiraGen Bio develops allogeneic CAR-T cell therapies optimized to overcome immunosuppression in solid tumor microenvironments. The company's KiraLOGIC platform uses machine learning to identify optimal combinations of gene edits that enhance CAR-T cell efficacy. By multiplex gene editing, KiraGen Bio reprograms cells to evade suppressive signals, preserving potency and extending responses even in hostile tumor environments. This approach aims to create resilient cell therapies effective against both solid and blood cancers.
Target Audience
KiraGen Bio's primary target audience includes researchers and clinicians focused on developing advanced cell therapies for solid tumors, as well as potential partners in the biotechnology and pharmaceutical industries.
Features
- AI-driven design leveraging machine learning to identify optimal gene editing combinations
- Multiplex gene editing to simultaneously edit multiple genes for enhanced CAR-T cell function
- Allogeneic CAR-T cells engineered to maintain efficacy against immunosuppressive solid tumor microenvironments
- KiraLOGIC platform predicts optimal multiplex edits using suppression data in a closed-loop system
- Models immune function using suppression-based readouts for predictive intelligence
- Screens billions of edits to find synergistic combinations
- Transferable learning, where every program improves design speed across T, NK, and γδ cells